About ENABLE BIOSCIENCES INC
Enable Biosciences is a biotechnology company spun out of UC Berkeley and Stanford in 2016, specializing in the development of tools for predictive medicine, particularly in the area of type 1 diabetes autoantibody testing. They have partnered with institutions such as Stanford Healthcare, Harvard Medical School, and the California Department of Public Health.
Development of tools for predictive medicineCreation of autoantibody tests for type 1 diabetesAdvanced screening methods for early detection of type 1 diabetesADAP technology for diabetes careResearch and development in immunology, protein biochemistry, and engineering
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ENABLE BIOSCIENCES INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.